An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...

The mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key immune ...

Beneficiaries of plans that covered fewer than the median number of DMTs in the past year were more likely to have a relapse, a study shows.

Early glucocorticoid initiation among patients with GCA was associated with a reduced risk for relapse and lower prednisone doses during tapering.

The vaccine ELI-002 2P showed favorable relapse-free survival and overall survival in patients with pancreatic and colorectal ...

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...

Patients with EM or CTD-related CryoVas often experience relapse following RTX and corticosteroid-induced remission.

Lower odds of relapse seen among Medicare beneficiaries in prescription drug plans, Medicare Advantage Prescription Drug plans.

This report details how pleomorphic breast carcinoma evaded initial treatment protocols and spread to 70% of the thorax ...